Target intelligence / Profile preview

Muscle spasms

01

Overview

Muscle spasms are involuntary, sudden, and often painful contractions of one or more muscles, typically resulting from muscle fatigue, dehydration, electrolyte imbalances, or underlying neurological conditions such as multiple sclerosis or spinal cord injuries (StatPearls, 2023). It is important to note that 'Muscle spasms' is a clinical symptom or medical condition rather than a specific molecular target like a receptor, enzyme, or ion channel (NIH, 2022). Pharmacological treatments, commonly referred to as muscle relaxants, do not 'target' the spasm itself but rather interact with specific proteins to modulate neuromuscular activity. For instance, baclofen acts as an agonist at GABA-B receptors to inhibit spinal reflexes, while tizanidine acts as an alpha-2 adrenergic agonist to increase presynaptic inhibition of motor neurons (PubMed, 2021). Because this entry describes a physiological manifestation of various pathologies rather than a single biological molecule, it is classified as an incorrect therapeutic target name for structured drug discovery databases.

Other names
Muscle crampInvoluntary muscle contractionMuscular hypertoniaSpasticityCharley horse
02

Mechanism of action

Muscle spasms are managed by drugs that target various pathways in the central nervous system to reduce motor neuron excitability, including GABA-B receptor agonism, alpha-2 adrenergic receptor agonism, and general CNS depression.

03

Biological functions

Muscle contractionNeuromuscular signaling
04

Disease associations

Musculoskeletal disorderNeuromuscular disorderMultiple sclerosisSpinal cord injuryCerebral palsy
05

Safety considerations

Central nervous system depressionSedation and drowsinessDizzinessRisk of physical dependence and abuseHepatotoxicity (specifically with tizanidine and metaxalone)Withdrawal symptoms upon abrupt discontinuation
06

Interacting drugs

Baclofen

7 more in the full profile.

07

Biomarkers

Electromyography (EMG) activityModified Ashworth Scale (MAS)Visual Analog Scale (VAS) for pain

Beyond the preview

Go deeper on Muscle spasms.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Muscle spasms.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call